Biliary stricture secondary to donor B-Cell lymphoma after orthopic liver transplantation

Liver Transplantation

Volumn 7, Issue 1, 2001, Pages 62-67

  Baron, Pedro W ^a   Heneghan, Michael A ^a   Suhocki, Paul V ^b   Nuckols, J Dean ^c   Tuttle Newhall, J Elizabeth ^a   Howell, David N ^c   Clavien, Pierre Alain ^a  

^a Departments of Surgery   (United States)

^b Departments of Radiation Oncology and Radiology   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; GANCICLOVIR; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOBLAST ANTIBODY; METHYLPREDNISOLONE; OKT 3; PLACEBO; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; B CELL LYMPHOMA; BILE DUCT OBSTRUCTION; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GRAFT REJECTION; HEPATOJEJUNOSTOMY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INVOLUTION; LIVER HILUS; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MEDICAL LITERATURE; MORBIDITY; MORTALITY; OBSTRUCTIVE JAUNDICE; ORGAN DONOR; PRIORITY JOURNAL; RECIPIENT; TUMOR REGRESSION;

EID: 0035187562     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2001.20781     Document Type: Article

References (30)

1. The incidence, timing and management of biliary tract complications after orthotopic liver transplantation
2. Biliary reconstruction for liver transplantation and management of biliary complications: Overview and survey of current practices in the United States
3. Diagnosis and treatment of biliary tract complications after orthotopic liver transplantation
4. Biliary tract complications after liver transplantation
5. Liver transplantation in man: The frequency of rejection, biliary tract complications, and recurrence of malignancy based on an analysis of 26 cases
6. Obstructive dilatation of extrahepatic recipient and donor bile ducts complicating orthotopic liver transplantation: Imaging and laboratory findings
7. Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation
8. Biliary strictures complicating liver transplantation: Incidence, pathogenesis, management, and outcome
9. Malignant lymphomas in transplantation patients
10. Liver transplantation under tacrolimus in infants, children, adults, and seniors: Long-term results, survival, and adverse events in 1000 consecutive patients
11. De novo malignancy following liver transplantation: A single-center study
12. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression
13. The surgical implications of the posttransplant lymphoproliferative disorders
14. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern
15. Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients
16. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation
17. The pathology of liver-localized post-transplant lymphoproliferative disease: A report of three cases and a review of the literature
18. Non-Hodgkin lymphoma in the porta hepatis after orthotopic liver transplantation: Sonographic findings
19. Lymphoproliferative disorder of donor origin in a liver transplant recipient: Complete remission after drastic reduction of immunosuppression without graft loss
20. Brief report: Lymphoma of donor origin occurring in the porta hepatis of a transplanted liver
21. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation
22. Post-transplant lymphoma in a liver allograft
23. Epstein-Barr virus-associated post-transplant lymphoproliferative disease of donor origin in liver transplant recipients
24. Lymphoproliferative disease after liver transplantation: Primary biliary localization
25. Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients
26. Immunosuppression-A contributory factor in lymphoma formation
27. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
28. Posttransplant lymphoproliferative disorders occurring under primary FK506 immunosuppression
29. De novo cancers in organ allograft recipients
30. The role of immunosuppression in lymphoma formation